View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 5, 2018

Hologic secures CE-Mark for tissue removal device MyoSure MANUAL

Hologic has secured the European CE-Mark for its MyoSure MANUAL device, which is designed to facilitate simple tissue removal procedures in any kind of setting.

Hologic has secured the European CE-Mark for its MyoSure MANUAL device, which is designed to facilitate simple tissue removal procedures in any kind of setting.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

MyoSure MANUAL features a fully integrated vacuum that does not require external suction, along with a 1lt saline bag, eliminating the requirement for a controller or additional fluid management equipment.

In addition, the clear tissue trap is included to enable visual confirmation of the tissue being removed during the procedure and allow detachment for sending the sample to pathology.

The device further facilitates multi-function control of the 360° blade for physicians.

Hologic Medical Affairs medical director and vice-president Edward Evantash said: “There is an increased demand to simplify tissue removal procedures regardless of where they are being performed, in-office or in the theatre.

“The MyoSure MANUAL device is designed to simplify tissue removal procedures in theatre, ambulatory or outpatient setting.”

“The MyoSure MANUAL device is designed to simplify tissue removal procedures in theatre, ambulatory or outpatient settings, requiring minimal set up and no fluid management capital equipment, while offering direct visualisation when used with the MyoSure hysteroscope.”

The new device expands the firm’s range of MyoSure gynecological surgical products, MyoSure, MyoSure REACH, MyoSure XL, and MyoSure LITE.

Hologic offers the complete MyoSure system as a minimally invasive hysteroscopic treatment for women with problematic tissue that does not need cauterisation.

The system is designed for fast and convenient removal of tissues such as various fibroids and polyps that might cause abnormal uterine bleeding (AUB).

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network